Anbio Biotechnology (NASDAQ:NNNN) Stock Price Up 4.4% – Here’s What Happened

Anbio Biotechnology (NASDAQ:NNNN) shot up 4.4% on Wednesday . The company traded as high as $8.00 and last traded at $8.1750. 7,010 shares changed hands during trading, a decline of 87% from the average daily volume of 55,502 shares. The stock had previously closed at $7.83.

Analysts Set New Price Targets

Separately, Weiss Ratings downgraded Anbio Biotechnology from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday, July 29th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company currently has a consensus rating of “Sell”.

Anbio Biotechnology Trading Down 2.2%

The stock’s 50-day simple moving average is $11.03 and its 200-day simple moving average is $20.37.

Anbio Biotechnology Company Profile

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.